{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:19:16Z","timestamp":1790216356110,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sjogren\u2019s disease (SjD) is an autoimmune disease that is characterized not only by the sicca symptoms it causes but also by its systemic nature, which is capable of several and not yet fully understood extraglandular manifestations. To gain a clearer understanding of these manifestations as well as a better practical approach, a panel of experts from the Brazilian Society of Rheumatology conducted a systematic review and meta-analysis on the identification of epidemiologic and clinical features of the extraglandular manifestations present in ESSDAI (EULAR Sjogren\u00b4s syndrome disease activity index), followed by a voting panel with recommendations for clinical practice. This publication is complementary to others already published and covers cutaneous and hematological manifestations, with prevalence data generated by a meta-analysis of 13 clinical or laboratory manifestations and 6 clinical management recommendations.<\/jats:p>","DOI":"10.1186\/s42358-024-00391-x","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T15:19:59Z","timestamp":1720538399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Recommendations on cutaneous and hematological manifestations of Sj\u00f6gren\u2019s disease by the Brazilian Society of Rheumatology"],"prefix":"10.1186","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0444-738X","authenticated-orcid":false,"given":"Alisson","family":"Pugliesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8236-024X","authenticated-orcid":false,"given":"Danielle Christinne Soares do","family":"Egypto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Duffles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8103-0532","authenticated-orcid":false,"given":"Diego Ust\u00e1rroz","family":"Cantali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7343-6804","authenticated-orcid":false,"given":"Sandra Gofinet","family":"Pasoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola Reis","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Valim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6971-5667","authenticated-orcid":false,"given":"Maria Lucia Lemos","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira Tatiyama","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilena Leal Mesquita Silvestre","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia Cristina de Magalh\u00e3es Souza","family":"Fialho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5075-8926","authenticated-orcid":false,"given":"Aysa C\u00e9sar","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Caldas dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Appenzeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4777-8659","authenticated-orcid":false,"given":"Sandra Lucia Euz\u00e9bio","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana Nayara","family":"Lib\u00f3rio-Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmen Lopes Ferreira Silva","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana D\u00b4Agostino","family":"Gennari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Pernanbuco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Gatz","family":"Capobiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius Tassoni","family":"Civile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina Pereira Nunes","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7190-0263","authenticated-orcid":false,"given":"C\u00e9sar Ramos","family":"Rocha-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Pereira da","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7180-6285","authenticated-orcid":false,"given":"Virginia Fernandes Mo\u00e7a","family":"Trevisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"issue":"2 Pt 1","key":"391_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.7326\/0003-4819-92-2-212","volume":"92","author":"HM Moutsopoulos","year":"1980","unstructured":"Moutsopoulos HM, Chused TM, Mann DL, Klippel JH, Fauci AS, Frank MM, et al. Sj\u00f6gren\u2019s syndrome (Sicca syndrome): current issues. Ann Intern Med. 1980 Feb;92(2 Pt 1):212\u201326. https:\/\/doi.org\/10.7326\/0003-4819-92-2-212.","journal-title":"Ann Intern Med"},{"issue":"5","key":"391_CR2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/s0049-0172(00)80016-5","volume":"29","author":"FN Skopouli","year":"2000","unstructured":"Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sj\u00f6gren\u2019s syndrome. Semin Arthritis Rheum. 2000 Apr;29(5):296\u2013304. https:\/\/doi.org\/10.1016\/s0049-0172(00)80016-5.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"391_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41584-023-01057-6","volume":"20","author":"M Beydon","year":"2024","unstructured":"Beydon M, McCoy S, Nguyen Y, Sumida T, Mariette X, Seror R. Epidemiology of Sj\u00f6gren syndrome. Nat Rev Rheumatol. 2024 Mar;20(3):158\u201369. https:\/\/doi.org\/10.1038\/s41584-023-01057-6.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"391_CR4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1590\/S0482-50042013000100003","volume":"53","author":"V Valim","year":"2013","unstructured":"Valim V, Zandonade E, Pereira AM, de Brito Filho OH, Serrano EV, Musso C, et al. Primary Sj\u00f6gren\u2019s syndrome prevalence in a major metropolitan area in Brazil. Rev Bras Reumatol. 2013 Feb;53(1):24\u201334.","journal-title":"Rev Bras Reumatol"},{"key":"391_CR5","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","volume":"2","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, et al. Sj\u00f6gren syndrome. Nat Rev Dis Primers. Jul 2016;2:16047. https:\/\/doi.org\/10.1038\/nrdp.2016.47.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"391_CR6","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/ard.2009.110619","volume":"69","author":"R Seror","year":"2010","unstructured":"Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, EULAR Sj\u00f6gren\u2019s Task Force, et al. EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome. Ann Rheum Dis. 2010 Jun;69(6):1103\u201309. https:\/\/doi.org\/10.1136\/ard.2009.110619. Epub 2009 Jun 28. Erratum in: Ann Rheum Dis. 2011 May;70(5):880.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"391_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s42358-022-00248-1","volume":"62","author":"VFM Trevisani","year":"2022","unstructured":"Trevisani VFM, Pugliesi A, Pasoto SG, Lopes MLL, Guedes LKN, Miyamoto ST, et al. Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary sjogren syndrome: results of an epidemiologic systematic review\/meta-analysis and a consensus guideline from the Brazilian Society of Rheumatology (articular, pulmonary and renal). Adv Rheumatol. 2022 Jun;62(1):18. https:\/\/doi.org\/10.1186\/s42358-022-00248-1.","journal-title":"Adv Rheumatol"},{"issue":"1","key":"391_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s42358-022-00267-y","volume":"62","author":"VFM Trevisani","year":"2022","unstructured":"Trevisani VFM, Pinheiro AC, de Magalh\u00e3es Souza Fialho SC, Fernandes MLMS, Pugliesi A, Pasoto SG, et al. Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary Sj\u00f6gren syndrome: results of an epidemiologic systematic review\/meta-analysis and a consensus guideline from the Brazilian society of rheumatology (hepatic, gastrointestinal and pancreatic). Adv Rheumatol. 2022 Oct;62(1):35. https:\/\/doi.org\/10.1186\/s42358-022-00267-y.","journal-title":"Adv Rheumatol"},{"issue":"4","key":"391_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/acr.21591","volume":"64","author":"SC Shiboski","year":"2012","unstructured":"Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, Sj\u00f6gren\u2019s International Collaborative Clinical Alliance (SICCA) Research Groups, et al. American College of Rheumatology classification criteria for Sj\u00f6gren\u2019s syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012 Apr;64(4):475\u201387. https:\/\/doi.org\/10.1002\/acr.21591.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"391_CR10","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, European Study Group on Classification Criteria for Sj\u00f6gren\u2019s Syndrome, et al. Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002 Jun;61(6):554\u201358. https:\/\/doi.org\/10.1136\/ard.61.6.554.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"391_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, International Sj\u00f6gren\u2019s Syndrome Criteria Working Group, et al. 2016 American College of Rheumatology\/European League against rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017 Jan;69(1):35\u201345. https:\/\/doi.org\/10.1002\/art.39859.","journal-title":"Arthritis Rheumatol"},{"key":"391_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JPT Higgins","year":"2019","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. Wiley; 2019. https:\/\/doi.org\/10.1002\/9781119536604."},{"issue":"3","key":"391_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.15171\/ijhpm.2014.71","volume":"3","author":"Z Munn","year":"2014","unstructured":"Munn Z, Moola S, Riitano D, Lisy K. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag. 2014 Aug;3(3):123\u201328. https:\/\/doi.org\/10.15171\/ijhpm.2014.71.","journal-title":"Int J Health Policy Manag"},{"issue":"3","key":"391_CR14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12016-017-8639-y","volume":"53","author":"E Generali","year":"2017","unstructured":"Generali E, Costanzo A, Mainetti C, Selmi C. Cutaneous and mucosal manifestations of Sj\u00f6gren\u2019s syndrome. Clin Rev Allergy Immunol. 2017 Dec;53(3):357\u201370. https:\/\/doi.org\/10.1007\/s12016-017-8639-y.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"20","key":"391_CR15","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.4103\/0366-6999.216403","volume":"130","author":"L Xuan","year":"2017","unstructured":"Xuan L, Zhang YD, Li L, Zeng YP, Zhang HZ, Wang J, et al. Clinical profile and significance of mucocutaneous lesions of primary Sj\u00f6gren\u2019s syndrome: a large cross-sectional study with 874 patients. Chin Med J (Engl). 2017 Oct;130(20):2423\u201328. https:\/\/doi.org\/10.4103\/0366-6999.216403.","journal-title":"Chin Med J (Engl)"},{"key":"391_CR16","first-page":"157","volume-title":"Sj\u00f6gren\u2019s Syndrome: diagnosis and Therapeutics","author":"H Walling","year":"2012","unstructured":"Walling H, Sontheimer R. Non-vasculitic cutaneous involvement. In: Ramos-Casals M, Stone J, Moutsopoulus H, editors. Sj\u00f6gren\u2019s Syndrome: diagnosis and Therapeutics. London: Springer-Verlag; 2012. p. 157\u201372."},{"issue":"1","key":"391_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2310\/7750.2010.09033","volume":"15","author":"A Kittridge","year":"2011","unstructured":"Kittridge A, Routhouska SB, Korman NJ. Dermatologic manifestations of Sj\u00f6gren syndrome. J Cutan Med Surg. 2011 Jan\u2013Feb;15(1):8\u201314. https:\/\/doi.org\/10.2310\/7750.2010.09033.","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"391_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jdermsci.2005.01.017","volume":"39","author":"E Bernacchi","year":"2005","unstructured":"Bernacchi E, Bianchi B, Amato L, Giorgini S, Fabbri P, Tavoni A, et al. Xerosis in primary Sj\u00f6gren syndrome: immunohistochemical and functional investigations. J Dermatol Sci. 2005 Jul;39(1):53\u201355. https:\/\/doi.org\/10.1016\/j.jdermsci.2005.01.017.","journal-title":"J Dermatol Sci"},{"issue":"12","key":"391_CR19","first-page":"741","volume":"42","author":"H Ueki","year":"1991","unstructured":"Ueki H, Inagaki Y, Hamasaki Y, Ono M. Dermatologische Manifestationen des Sj\u00f6gren-Syndroms [Dermatological manifestations of Sj\u00f6gren\u2019s syndrome. Hautarzt. 1991 Dec;42(12):741\u201347. (German).","journal-title":"Hautarzt"},{"issue":"5","key":"391_CR20","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/j.1365-2133.1995.tb02744.x","volume":"133","author":"I Katayama","year":"1995","unstructured":"Katayama I, Yokozeki H, Nishioka K. Impaired sweating as an exocrine manifestation in Sj\u00f6gren\u2019s syndrome. Br J Dermatol. 1995 Nov;133(5):716\u201320. https:\/\/doi.org\/10.1111\/j.1365-2133.1995.tb02744.x.","journal-title":"Br J Dermatol"},{"issue":"2","key":"391_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1046\/j.1365-2133.1997.18091892.x","volume":"137","author":"M Engelke","year":"1997","unstructured":"Engelke M, Jensen JM, Ekanayake-Mudiyanselage S, Proksch E. Effects of xerosis and ageing on epidermal proliferation and differentiation. Br J Dermatol. 1997 Aug;137(2):219\u201325. https:\/\/doi.org\/10.1046\/j.1365-2133.1997.18091892.x.","journal-title":"Br J Dermatol"},{"key":"391_CR22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0889-857X(21)00319-7","volume":"18","author":"TT Provost","year":"1992","unstructured":"Provost TT, Watson R. Cutaneous manifestations of Sj\u00f6gren\u2019s syndrome. Rheum Dis Clin North Am. 1992;18:609\u201316. https:\/\/doi.org\/10.1016\/S0889-857X(21)00319-7.","journal-title":"Rheum Dis Clin North Am"},{"key":"391_CR23","unstructured":"Bernacchi E, Amato L, Parodi A, Cottoni F, Rubegni P, De Pit\u00e0 O, et al. Sj\u00f6gren\u2019s syndrome: a retrospective review of the cutaneous features of 93 patients by the Italian Group of Immunodermatology. Clin Exp Rheumatol. 2004;22."},{"key":"391_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1365-4362.1994.tb04044.x","volume":"33","author":"I Katayama","year":"1994","unstructured":"Katayama I, Koyano T, Nishioka K. Prevalence of eyelid dermatitis in primary Sj\u00f6gren\u2019s syndrome. Int J Dermatol. 1994;33:421\u201324. https:\/\/doi.org\/10.1111\/j.1365-4362.1994.tb04044.x.","journal-title":"Int J Dermatol"},{"issue":"9","key":"391_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1365-4362.1991.tb03489.x","volume":"30","author":"I Katayama","year":"1991","unstructured":"Katayama I, Teramoto N, Arai H, Nishioka K, Nishiyama S. Annular erythema. A comparative study of Sj\u00f6gren syndrome with subacute cutaneous lupus erythematosus. Int J Dermatol. 1991 Sep;30(9):635\u201339. https:\/\/doi.org\/10.1111\/j.1365-4362.1991.tb03489.x.","journal-title":"Int J Dermatol"},{"key":"391_CR26","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1067\/mjd.2000.105508","volume":"42","author":"JE Haimowitz","year":"2000","unstructured":"Haimowitz JE, McCauliffe DP, Seykora J, Werth VP. Annular erythema of Sj\u00f6gren\u2019s syndrome in a white woman. J Am Acad Dermatol. 2000;42:1069\u201373. https:\/\/doi.org\/10.1067\/mjd.2000.105508.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"391_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/0961203313515764","volume":"23","author":"P Brito-Zer\u00f3n","year":"2014","unstructured":"Brito-Zer\u00f3n P, Retamozo S, Akasbi M, Gand\u00eda M, Perez-De-Lis M, Soto-Cardenas MJ, et al. Annular erythema in primary Sjogren\u2019s syndrome: description of 43 non-Asian cases. Lupus. 2014 Feb;23(2):166\u201375. https:\/\/doi.org\/10.1177\/0961203313515764.","journal-title":"Lupus"},{"key":"391_CR28","unstructured":"Hsu S, Le EH, Khoshevis MR. Differential diagnosis of annular lesions. Am Fam Physician. 2001;64."},{"key":"391_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-0-85729-358-9_5","volume-title":"Autoimmune Diseases: acute and Complex Situations","author":"M Ramos-Casals","year":"2011","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Bov\u00e9 A, Sis\u00f3-Almirall A. Sj\u00f6gren\u2019s syndrome: beyond sicca involvement. In: Khamasha M, Ramos-Casals M, editors. Autoimmune Diseases: acute and Complex Situations. London: Springer-Verlag; 2011. p. 45\u201366."},{"issue":"6","key":"391_CR30","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/ard.2010.143743","volume":"70","author":"R Seror","year":"2011","unstructured":"Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, EULAR Sj\u00f6gren\u2019s Task Force, et al. EULAR Sjogren\u2019s Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren\u2019s syndrome. Ann Rheum Dis. 2011 Jun;70(6):968\u201372. https:\/\/doi.org\/10.1136\/ard.2010.143743.","journal-title":"Ann Rheum Dis"},{"key":"391_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jaut.2013.12.010","volume":"51","author":"R Seror","year":"2014","unstructured":"Seror R, Theander E, Bootsma H, Bowman SJ, Tzioufas A, Gottenberg JE, et al. Outcome measures for primary Sj\u00f6gren\u2019s syndrome: a comprehensive review. J Autoimmun. Jun 2014;51:51\u201356. https:\/\/doi.org\/10.1016\/j.jaut.2013.12.010.","journal-title":"J Autoimmun"},{"issue":"1","key":"391_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5114\/pdia.2016.57764","volume":"33","author":"K B\u0142ochowiak","year":"2016","unstructured":"B\u0142ochowiak K, Olewicz-Gawlik A, Pola\u0144ska A, Nowak-Gabryel M, Koci\u0119cki J, Witmanowski H, et al. Oral mucosal manifestations in primary and secondary Sj\u00f6gren syndrome and dry mouth syndrome. Postepy Dermatol Alergol. 2016 Feb;33(1):23\u201327. https:\/\/doi.org\/10.5114\/pdia.2016.57764.","journal-title":"Postepy Dermatol Alergol"},{"issue":"5","key":"391_CR33","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/1523-1747.ep12552002","volume":"80","author":"EL Alexander","year":"1983","unstructured":"Alexander EL, Provost TT. Cutaneous manifestations of primary Sj\u00f6gren\u2019s syndrome: a reflection of vasculitis and association with anti-Ro(SSA) antibodies. J Invest Dermatol. 1983 May;80(5):386\u201391. https:\/\/doi.org\/10.1111\/1523-1747.ep12552002.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"391_CR34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/01.md.0000119465.24818.98","volume":"83","author":"M Ramos-Casals","year":"2004","unstructured":"Ramos-Casals M, Anaya JM, Garc\u00eda-Carrasco M, Rosas J, Bov\u00e9 A, Claver G, et al. Cutaneous vasculitis in primary Sj\u00f6gren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore). 2004 Mar;83(2):96\u2013106. https:\/\/doi.org\/10.1097\/01.md.0000119465.24818.98.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"391_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/BOR.0000000000000346","volume":"29","author":"C Demirkesen","year":"2017","unstructured":"Demirkesen C. Approach to cutaneous vasculitides with special emphasis on small vessel vasculitis: histopathology and direct immunofluorescence. Curr Opin Rheumatol. 2017 Jan;29(1):39\u201344. https:\/\/doi.org\/10.1097\/BOR.0000000000000346.","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"391_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.7150\/ijms.17718","volume":"14","author":"T Both","year":"2017","unstructured":"Both T, Dalm VA, van Hagen PM, van Daele PL. Reviewing primary Sj\u00f6gren\u2019s syndrome: beyond the dryness - from pathophysiology to diagnosis and treatment. Int J Med Sci. 2017 Feb;14(3):191\u2013200. https:\/\/doi.org\/10.7150\/ijms.17718.","journal-title":"Int J Med Sci"},{"issue":"1","key":"391_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/rheumatology\/keh407","volume":"44","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Yag\u00fce J, Akasbi M, Bautista R, Ruano M, et al. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren\u2019s syndrome. Rheumatology (Oxford). 2005 Jan;44(1):89\u201394. https:\/\/doi.org\/10.1093\/rheumatology\/keh407.","journal-title":"Rheumatology (Oxford)"},{"key":"391_CR38","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1136\/jnnp.57.8.983","volume":"57","author":"F Gemignani","year":"1994","unstructured":"Gemignani F, Marbini A, Pavesi G, Di Vittorio S, Manganelli P, Cenacchi G, et al. Peripheral neuropathy associated with primary Sjogren\u2019s syndrome. J Neurol Neurosurg Psychiatry. 1994;57:983\u201386.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"391_CR39","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/art.1780390508","volume":"39","author":"AG Tzioufas","year":"1996","unstructured":"Tzioufas AG, Boumba DS, Skopouli FN, Moutsopoulos HM. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 1996;39:767\u201372. https:\/\/doi.org\/10.1002\/art.1780390508.","journal-title":"Arthritis Rheum"},{"issue":"5 Suppl 51","key":"391_CR40","first-page":"S66","volume":"26","author":"M Voulgarelis","year":"2008","unstructured":"Voulgarelis M, Tzioufas AG, Moutsopoulos HM. Mortality in Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol. 2008 Sep\u2013Oct;26(5 Suppl 51):S66\u201371.","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"391_CR41","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1002\/art.23617","volume":"58","author":"JM Meijer","year":"2008","unstructured":"Meijer JM, Schonland SO, Palladini G, Merlini G, Hegenbart U, Ciocca O, et al. Sj\u00f6gren\u2019s syndrome and localized nodular cutaneous amyloidosis: coincidence or a distinct clinical entity? Arthritis Rheum. 2008 Jul;58(7):1992\u201399. https:\/\/doi.org\/10.1002\/art.23617.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"391_CR42","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1346-8138.2002.tb00244.x","volume":"29","author":"T Yamamoto","year":"2002","unstructured":"Yamamoto T, Ohi M, Nishioka K. Lymphomatoid papulosis associated with Sj\u00f6gren\u2019s syndrome. J Dermatol. 2002 Mar;29(3):174\u201377. https:\/\/doi.org\/10.1111\/j.1346-8138.2002.tb00244.x.","journal-title":"J Dermatol"},{"issue":"2","key":"391_CR43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1346-8138.2006.00232.x","volume":"34","author":"H Tsuboi","year":"2007","unstructured":"Tsuboi H, Katsuoka K. Ulcerative lichen planus associated with Sj\u00f6gren\u2019s syndrome. J Dermatol. 2007 Feb;34(2):131\u201334. https:\/\/doi.org\/10.1111\/j.1346-8138.2006.00232.x.","journal-title":"J Dermatol"},{"issue":"11","key":"391_CR44","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/j.1365-4632.2004.02290.x","volume":"44","author":"D Tsuruta","year":"2005","unstructured":"Tsuruta D, Matsumura-Oura A, Ishii M. Subcorneal pustular dermatosis and Sj\u00f6gren\u2019s syndrome. Int J Dermatol. 2005 Nov;44(11):955\u201357. https:\/\/doi.org\/10.1111\/j.1365-4632.2004.02290.x.","journal-title":"Int J Dermatol"},{"issue":"2","key":"391_CR45","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2177\/jsci.23.124","volume":"23","author":"A Aoki","year":"2000","unstructured":"Aoki A, Ohno S, Ueda A, Ideguchi H, Ohkubo T, Hagiwara E, et al. [Hematological abnormalities of primary Sjogren\u2019s syndrome]. Nihon Rinsho Meneki Gakkai Kaishi. 2000 Apr;23(2):124\u201328 (Japanese). https:\/\/doi.org\/10.2177\/jsci.23.124.","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"issue":"5","key":"391_CR46","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.semarthrit.2008.01.014","volume":"38","author":"P Brito-Zer\u00f3n","year":"2009","unstructured":"Brito-Zer\u00f3n P, Soria N, Mu\u00f1oz S, Bov\u00e9 A, Akasbi M, Belenguer R, et al. Prevalence and clinical relevance of autoimmune neutropenia in patients with primary Sj\u00f6gren\u2019s syndrome. Semin Arthritis Rheum. 2009 Apr;38(5):389\u201395. https:\/\/doi.org\/10.1016\/j.semarthrit.2008.01.014.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"391_CR47","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","volume":"87","author":"M Ramos-Casals","year":"2008","unstructured":"Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J, GEMESS Study Group, et al. Primary Sj\u00f6gren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore). 2008 Jul;87(4):210\u201319. https:\/\/doi.org\/10.1097\/MD.0b013e318181e6af.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"391_CR48","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/rheumatology\/ket427","volume":"53","author":"C Baldini","year":"2014","unstructured":"Baldini C, Pepe P, Quartuccio L, Priori R, Bartoloni E, Alunno A, et al. Primary Sjogren\u2019s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology (Oxford). 2014 May;53(5):839\u201344. https:\/\/doi.org\/10.1093\/rheumatology\/ket427.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"391_CR49","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/rheumatology\/ket349","volume":"53","author":"M Ramos-Casals","year":"2014","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Solans R, Camps MT, Casanovas A, Sope\u00f1a B, SS Study Group; Autoimmune Diseases Study Group (GEAS) of the Spanish Society of Internal Medicine (SEMI), et al. Systemic involvement in primary Sjogren\u2019s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). Rheumatology (Oxford). 2014 Feb;53(2):321\u201331. https:\/\/doi.org\/10.1093\/rheumatology\/ket349.","journal-title":"Rheumatology (Oxford)"},{"key":"391_CR50","unstructured":"Friedman JA, Miller EB, Green L, Huszar M, Schattner A. A community-based cohort of 201 consecutive patients with primary Sj\u00f6gren\u2019s syndrome in Israel: ashkenazi patients compared with those of Sephardic descent. Clin Exp Rheumatol. 2006;24."},{"key":"391_CR51","unstructured":"Barcelos F, Abreu I, Patto JV, Trindade H, Teixeira A. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sj\u00f6gren\u2019s syndrome. Acta Reumatol Port. 2009;34."},{"issue":"5","key":"391_CR52","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","volume":"88","author":"E Baimpa","year":"2009","unstructured":"Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM. Hematologic manifestations and predictors of lymphoma development in primary Sj\u00f6gren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore). 2009 Sep;88(5):284\u201393. https:\/\/doi.org\/10.1097\/MD.0b013e3181b76ab5.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"391_CR53","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10067-009-1366-x","volume":"29","author":"JG Zhou","year":"2010","unstructured":"Zhou JG, Qing YF, Jiang L, Yang QB, Luo WF. Clinical analysis of primary Sj\u00f6gren\u2019s syndrome complicating anemia. Clin Rheumatol. 2010 May;29(5):525\u201329. https:\/\/doi.org\/10.1007\/s10067-009-1366-x.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"391_CR54","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00296-012-2570-6","volume":"33","author":"P Caramaschi","year":"2013","unstructured":"Caramaschi P, Biasi D, Caimmi C, Scambi C, Pieropan S, Barausse G, et al. The co-occurrence of Hashimoto thyroiditis in primary Sjogren\u2019s syndrome defines a subset of patients with milder clinical phenotype. Rheumatol Int. 2013 May;33(5):1271\u201375. https:\/\/doi.org\/10.1007\/s00296-012-2570-6.","journal-title":"Rheumatol Int"},{"issue":"6","key":"391_CR55","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/acr.21610","volume":"64","author":"AS Malladi","year":"2012","unstructured":"Malladi AS, Sack KE, Shiboski SC, Shiboski CH, Baer AN, Banushree R, et al. Primary Sj\u00f6gren\u2019s syndrome as a systemic disease: a study of participants enrolled in an international Sj\u00f6gren\u2019s syndrome registry. Arthritis Care Res (Hoboken). 2012 Jun;64(6):911\u201318. https:\/\/doi.org\/10.1002\/acr.21610.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"391_CR56","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/rheumatology\/kew194","volume":"55","author":"S Retamozo","year":"2016","unstructured":"Retamozo S, Gheitasi H, Quartuccio L, Kostov B, Corazza L, Bov\u00e9 A, et al. Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sj\u00f6gren syndrome: analysis of 515 patients. Rheumatology (Oxford). 2016 Aug;55(8):1443\u201351. https:\/\/doi.org\/10.1093\/rheumatology\/kew194.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"391_CR57","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/0961203319889666","volume":"29","author":"D Xu","year":"2020","unstructured":"Xu D, Zhao S, Li Q, Wang YH, Zhao JL, Li MT, et al. Characteristics of Chinese patients with primary Sj\u00f6gren\u2019s syndrome: preliminary report of a multi-centre registration study. Lupus. 2020 Jan;29(1):45\u201351. https:\/\/doi.org\/10.1177\/0961203319889666.","journal-title":"Lupus"},{"key":"391_CR58","doi-asserted-by":"publisher","unstructured":"Ramakrishna R, Chaudhuri K, Sturgess A, Manoharan A. Haematological manifestations of primary Sj\u00f6gren\u2019s syndrome: a clinicopathological study. QJM. 1992;83. https:\/\/doi.org\/10.1093\/oxfordjournals.qjmed.a068692.","DOI":"10.1093\/oxfordjournals.qjmed.a068692"},{"issue":"50","key":"391_CR59","doi-asserted-by":"publisher","first-page":"e5565","DOI":"10.1097\/MD.0000000000005565","volume":"95","author":"Y Liu","year":"2016","unstructured":"Liu Y, Chen S, Sun Y, Lin Q, Liao X, Zhang J, et al. Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: a retrospective study. Medicine (Baltimore). 2016 Dec;95(50):e5565. https:\/\/doi.org\/10.1097\/MD.0000000000005565.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"391_CR60","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/art.20176","volume":"50","author":"E Theander","year":"2004","unstructured":"Theander E, Manthorpe R, Jacobsson LT. Mortality and causes of death in primary Sj\u00f6gren\u2019s syndrome: a prospective cohort study. Arthritis Rheum. 2004 Apr;50(4):1262\u201369. https:\/\/doi.org\/10.1002\/art.20176.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"391_CR61","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/art.10221","volume":"46","author":"JP Ioannidis","year":"2002","unstructured":"Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 2002 Mar;46(3):741\u201347. https:\/\/doi.org\/10.1002\/art.10221.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"391_CR62","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3899\/jrheum.161465","volume":"44","author":"L Quartuccio","year":"2017","unstructured":"Quartuccio L, Baldini C, Priori R, Bartoloni E, Carubbi F, Alunno A, GRISS Group, et al. Cryoglobulinemia in Sj\u00f6gren syndrome: a disease subset that links higher systemic disease activity, autoimmunity, and local B cell proliferation in mucosa-associated lymphoid tissue. J Rheumatol. 2017 Aug;44(8):1179\u201383. https:\/\/doi.org\/10.3899\/jrheum.161465.","journal-title":"J Rheumatol"},{"issue":"6","key":"391_CR63","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1136\/annrheumdis-2016-209952","volume":"76","author":"P Brito-Zer\u00f3n","year":"2017","unstructured":"Brito-Zer\u00f3n P, Acar-Denizli N, Zeher M, Rasmussen A, Seror R, Theander E, EULAR-SS Task Force Big Data Consortium, et al. Influence of geolocation and ethnicity on the phenotypic expression of primary Sj\u00f6gren\u2019s syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sj\u00f6gren Project Consortium. Ann Rheum Dis. 2017 Jun;76(6):1042\u201350. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209952.","journal-title":"Ann Rheum Dis"},{"key":"391_CR64","doi-asserted-by":"publisher","unstructured":"Lin DF, Yan SM, Zhao Y, Zhang W, Li MT, Zeng XF, et al. Clinical and prognostic characteristics of 573 cases of primary Sj\u00f6gren\u2019s syndrome. Chin Med J (Engl). 2010:123. https:\/\/doi.org\/10.3760\/cma.j.issn.0366-6999.2010.22.015.","DOI":"10.3760\/cma.j.issn.0366-6999.2010.22.015"},{"issue":"6","key":"391_CR65","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/rheumatology\/keq047","volume":"49","author":"AL Fauchais","year":"2010","unstructured":"Fauchais AL, Ouattara B, Gondran G, Lallou\u00e9 F, Petit D, Ly K, et al. Articular manifestations in primary Sj\u00f6gren\u2019s syndrome: clinical significance and prognosis of 188 patients. Rheumatology (Oxford). 2010 Jun;49(6):1164\u201372. https:\/\/doi.org\/10.1093\/rheumatology\/keq047.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"391_CR66","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.semarthrit.2013.03.001","volume":"43","author":"AP Risselada","year":"2013","unstructured":"Risselada AP, Kruize AA, Bijlsma JW. Clinical features distinguishing lymphoma development in primary Sj\u00f6gren\u2019s syndrome-a retrospective cohort study. Semin Arthritis Rheum. 2013 Oct;43(2):171\u201377. https:\/\/doi.org\/10.1016\/j.semarthrit.2013.03.001.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"391_CR67","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/rheumatology\/kei107","volume":"45","author":"Y Alamanos","year":"2006","unstructured":"Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA. Epidemiology of primary Sj\u00f6gren\u2019s syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford). 2006 Feb;45(2):187\u201391. https:\/\/doi.org\/10.1093\/rheumatology\/kei107.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"391_CR68","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/s0049-0172(98)80037-1","volume":"28","author":"M Ramos-Casals","year":"1998","unstructured":"Ramos-Casals M, Cervera R, Yag\u00fce J, Garc\u00eda-Carrasco M, Trejo O, Jim\u00e9nez S, et al. Cryoglobulinemia in primary Sj\u00f6gren\u2019s syndrome: prevalence and clinical characteristics in a series of 115 patients. Semin Arthritis Rheum. 1998 Dec;28(3):200\u201305. https:\/\/doi.org\/10.1016\/s0049-0172(98)80037-1.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"391_CR69","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/00005792-200207000-00003","volume":"81","author":"M Garc\u00eda-Carrasco","year":"2002","unstructured":"Garc\u00eda-Carrasco M, Ramos-Casals M, Rosas J, Pallar\u00e9s L, Calvo-Alen J, Cervera R, et al. Primary Sj\u00f6gren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002 Jul;81(4):270\u201380. https:\/\/doi.org\/10.1097\/00005792-200207000-00003.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"391_CR70","first-page":"66","volume":"62","author":"VI Vasil\u2019ev","year":"1990","unstructured":"Vasil\u2019ev VI, Khodarev NV, Mach ES, Manu\u012dlova LS, Simonova MV, Svobodina ON, et al. Krioglobulinemiia pri bolezni Shegrena [Cryoglobulinemia in Sj\u00f6gren\u2019s syndrome. Ter Arkh. 1990;62(5):66\u201370 (Russian).","journal-title":"Ter Arkh"},{"issue":"8","key":"391_CR71","first-page":"61","volume":"76","author":"VI Vasil\u2019ev","year":"2004","unstructured":"Vasil\u2019ev VI, Probatova NA, Varlamova E, Tupitsin NN, Simonova MV, Safonova TN, et al. Prognosticheskoe znachenie smeshanno\u012d monoclonal\u2019no\u012d krioglobulinemii pri bolezni Shegrena [Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren\u2019s disease]. Ter Arkh. 2004;76(8):61\u201368 (Russian).","journal-title":"Ter Arkh"},{"issue":"8","key":"391_CR72","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","volume":"111","author":"K Ekstr\u00f6m Smedby","year":"2008","unstructured":"Ekstr\u00f6m Smedby K, Vajdic CM, Falster M, Engels EA, Mart\u00ednez-Maza O, Turner J, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008 Apr;111(8):4029\u201338. https:\/\/doi.org\/10.1182\/blood-2007-10-119974.","journal-title":"Blood"},{"issue":"2","key":"391_CR73","doi-asserted-by":"publisher","first-page":"e0116189","DOI":"10.1371\/journal.pone.0116189","volume":"10","author":"A Papageorgiou","year":"2015","unstructured":"Papageorgiou A, Ziogas DC, Mavragani CP, Zintzaras E, Tzioufas AG, Moutsopoulos HM, et al. Predicting the outcome of Sjogren\u2019s syndrome-associated non-hodgkin\u2019s lymphoma patients. PLoS One. 2015 Feb;10(2):e0116189. https:\/\/doi.org\/10.1371\/journal.pone.0116189.","journal-title":"PLoS One"},{"issue":"2","key":"391_CR74","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.autrev.2018.08.007","volume":"18","author":"AV Goules","year":"2019","unstructured":"Goules AV, Tzioufas AG. Lymphomagenesis in Sj\u00f6gren\u2019s syndrome: predictive biomarkers towards precision medicine. Autoimmun Rev. 2019 Feb;18(2):137\u201343. https:\/\/doi.org\/10.1016\/j.autrev.2018.08.007.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"391_CR75","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/bjh.15953","volume":"186","author":"B Kiesewetter","year":"2019","unstructured":"Kiesewetter B, Lamm W, Dolak W, Lukas J, Mayerhoefer ME, Weber M, et al. Transformed mucosa-associated lymphoid tissue lymphomas: a single institution retrospective study including polymerase chain reaction-based clonality analysis. Br J Haematol. 2019 Aug;186(3):448\u201359. https:\/\/doi.org\/10.1111\/bjh.15953.","journal-title":"Br J Haematol"},{"issue":"20","key":"391_CR76","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016 May;127(20):2375\u201390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569.","journal-title":"Blood"},{"issue":"1","key":"391_CR77","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00296-014-3051-x","volume":"35","author":"MB Nishishinya","year":"2015","unstructured":"Nishishinya MB, Pereda CA, Mu\u00f1oz-Fern\u00e1ndez S, Pego-Reigosa JM, R\u00faa-Figueroa I, Andreu JL, et al. Identification of lymphoma predictors in patients with primary Sj\u00f6gren\u2019s syndrome: a systematic literature review and meta-analysis. Rheumatol Int. 2015 Jan;35(1):17\u201326. https:\/\/doi.org\/10.1007\/s00296-014-3051-x.","journal-title":"Rheumatol Int"},{"issue":"25","key":"391_CR78","doi-asserted-by":"publisher","first-page":"e3766","DOI":"10.1097\/MD.0000000000003766","volume":"95","author":"S Fragkioudaki","year":"2016","unstructured":"Fragkioudaki S, Mavragani CP, Moutsopoulos HM. Predicting the risk for lymphoma development in Sjogren syndrome: an easy tool for clinical use. Medicine (Baltimore). 2016 Jun;95(25):e3766. https:\/\/doi.org\/10.1097\/MD.0000000000003766.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"391_CR79","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/lary.23901","volume":"123","author":"AJ Feinstein","year":"2013","unstructured":"Feinstein AJ, Ciarleglio MM, Cong X, Otremba MD, Judson BL. Parotid gland lymphoma: prognostic analysis of 2140 patients. Laryngoscope. 2013 May;123(5):1199\u2013203. https:\/\/doi.org\/10.1002\/lary.23901.","journal-title":"Laryngoscope"},{"issue":"17","key":"391_CR80","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1182\/blood-2015-12-624304","volume":"127","author":"E Zucca","year":"2016","unstructured":"Zucca E, Bertoni F. The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance. Blood. 2016 Apr;127(17):2082\u201392. https:\/\/doi.org\/10.1182\/blood-2015-12-624304.","journal-title":"Blood"},{"issue":"1","key":"391_CR81","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40644-020-00380-5","volume":"21","author":"K Kws","year":"2021","unstructured":"Kws K, Bhatia KS, Qyh A, King AD. Imaging of head and neck mucosa-associated lymphoid tissue lymphoma (MALToma). Cancer Imaging. 2021 Jan;21(1):10. https:\/\/doi.org\/10.1186\/s40644-020-00380-5.","journal-title":"Cancer Imaging"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-024-00391-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-024-00391-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-024-00391-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T15:27:31Z","timestamp":1720538851000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-024-00391-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["391"],"URL":"https:\/\/doi.org\/10.1186\/s42358-024-00391-x","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,9]]},"assertion":[{"value":"16 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AP: None; DCSE: None; DUC: None; GD: None; SGP: None; FRO: None; VV: None MLLL: None; STM: None; MLMSF: None; SCMSF: None; ACP: None; LCS: None; SA: None; SLER: None; TNLK: None; MCLFSS: None; JDG: None; RP: None; KGC: None;. VTC: None; ACPNP: None; CRRF: None; APR: None; VFMT: None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}